Skip to main content

Year: 2023

Foremost Lithium Issues Shareholder Letter and Provides Corporate Update

VANCOUVER, British Columbia, Dec. 12, 2023 (GLOBE NEWSWIRE) — Foremost Lithium Resource & Technology Ltd. (NASDAQ: FMST) (CSE: FAT) (“Foremost Lithium”, “Foremost” or the “Company”), a North American hard-rock lithium exploration company, today issued a letter to shareholders from its President and Chief Executive Officer, Jason Barnard. Dear Shareholders, 2023 was a transformational year for Foremost Lithium, building the foundation for success in our 2024 drilling programs as we advance project timelines at our asset rich, strategically located hard-rock lithium properties in North America. Throughout the year, we have extended our land claims into eastern Canada, continued our exploration and growth on our Lithium Lane projects in Manitoba, executed on the drills, with lithium and gold discovery and completed property acquisitions. On...

Continue reading

Deep Green Waste & Recycling Reports Record Third Quarter Earnings

Revenues Increase 140 Percent and Operating Profits Increase Saint Simons Island, Georgia, Dec. 12, 2023 (GLOBE NEWSWIRE) — Deep Green Waste & Recycling Inc. (OTC PINK: DGWR), a waste, recycling and remediation services company for commercial customers, today announces strong top and bottom line growth in its financial results for the third quarter and nine months ended Sept. 30, 2023. Revenues increased by 145 percent to a quarterly record of $902,987 compared to $368,512 in the third quarter 2022 based on robust organic growth and recent acquisitions. Impressive gross margins of 82 percent and prudent expense management led to substantial profitability growth. “I am thrilled to report that the immense effort put forth by our dedicated team to methodically improve performance over the past year has resulted in an organization...

Continue reading

SP Plus Corporation Upgrades Parking Services on the University of Akron Campus

CHICAGO, Dec. 12, 2023 (GLOBE NEWSWIRE) — SP+® Corporation (SP+), (Nasdaq: SP) a best-in-class technology and operations management provider of mobility services for aviation, commercial, hospitality, and institutional clients throughout North America and Europe, today announced an agreement to operate, manage, and maintain the University of Akron’s parking system at the main campus in Akron, Ohio. The University of Akron has entered into a 35-year parking monetization, structured as a tax-exempt bond transaction, with a team led by Diogenes Capital, SP+, and KeyBanc Capital Markets. This agreement, with UAkronPark, Inc. as Concessionaire, has generated a significant up-front payment of $55 million for the University and will continue to provide ongoing revenue of approximately $75 million over the term, allowing the institution...

Continue reading

Cellectar Biosciences Strengthens Intellectual Property Protection for its PDC Platform

Expanded Global Patent Provides Protection for Phospholipid Drug Conjugate™ (PDC) Platform to Deliver Flavaglines as Targeted Anticancer Payloads FLORHAM PARK, N.J., Dec. 12, 2023 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announced that is has received Notice of Allowance for the patent titled, “Phospholipid-flavagline conjugates and methods of using the same for targeted cancer therapy,” from the Japanese, Chinese, Eurasian, Brazilian, and Mexican patent authorities. These patent allowances in key global regions follow prior allowances for the same patent in the US, Europe, Australia and Canada. The patent provides composition of matter and use protection...

Continue reading

VERB’s MARKET.live Adds Five More Retail Brands to Its Livestream Social Shopping Platform

LOS ALAMITOS, Calif. and LAS VEGAS, Dec. 12, 2023 (GLOBE NEWSWIRE) — Verb Technology Company, Inc. (Nasdaq: VERB) (“VERB” or the “Company”), the company behind MARKET.live, the innovative multi-vendor, multi-presenter livestream social shopping platform, announces five more dynamic new brands have joined the MARKET.live platform this week. The recent completion of the Company’s tech integrations with the ecommerce solutions powering thousands of vendors’ existing ecommerce stores are continuing to drive demand from retailers eager to create new and additional distribution channels and affiliate relationships through MARKET.live. Brands, retailers and creators that join MARKET.live have the ability to broadcast livestream shopping events simultaneously on numerous social media channels, including TikTok,...

Continue reading

TransCode Therapeutics Reports Positive Pre-Clinical Results in Metastatic Pancreatic Cancer with its Lead Candidate, TTX-MC138

TTX-MC138 is Effective in Animal Models of Human Metastatic Pancreatic Cancer BOSTON, Dec. 12, 2023 (GLOBE NEWSWIRE) — TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today reported successful completion of a preclinical study comprising four independent replicates with its lead therapeutic candidate, TTX-MC138, in pancreatic adenocarcinoma (PDAC). The study demonstrated that TTX-MC138 was effective against metastatic (stage IV) pancreatic cancer in animal models. There are currently no treatment options for patients with metastatic (stage IV) pancreatic cancer beyond palliative care. The study involved weekly injection of TTX-MC138 into animals bearing human pancreatic tumors. Treatment was initiated after the tumors were established and...

Continue reading

NightHawk Biosciences Announces Strategic Shift into a Pure-Play Large Molecule Biomanufacturing CDMO to Capitalize on Rapid Growth in Sales Pipeline along with Divestiture of Non-Core Assets

Over $20 million in signed manufacturing contracts which includepremier biotech/pharma companies and research institutes Elusys divestiture and R&D cuts expected to eliminate over $40 million in commitments and reduce operating expenses by more than $13 million per year DURHAM, N.C., Dec. 12, 2023 (GLOBE NEWSWIRE) — NightHawk Biosciences (NYSE American: NHWK) today (“NightHawk” or the “Company”) announced its strategic shift into a pure-play biomanufacturing Contract Development & Manufacturing Organization (CDMO), as well as the divestiture of certain non-core assets, in order to focus on the growing sales within its Scorpius BioManufacturing subsidiary (“Scorpius”). The Company has booked contracts thus far in 2023, Scorpius’ first full year of operation, that are expected to generate over $20 million in revenue, a...

Continue reading

Top Ships Announces Increase From Previously Announced Management Estimate of Net Asset Value to $344 Million and Contracted Revenue Backlog of $400 Million

ATHENS, Greece, Dec. 12, 2023 (GLOBE NEWSWIRE) — TOP Ships Inc. (the “Company” or “Top Ships”) (NASDAQ:TOPS), an international owner and operator of modern, fuel efficient “ECO” tanker vessels, announced today that after taking into account the most recent charter free vessel value estimates from a third party international broker, debt outstanding and cash, management estimates the Company’s net asset value (“NAV”) as of December 12, 2023 to be $344 million, increased from the previously-announced estimate of $285 million as of June 30, 2023. This translates into a NAV of $74.36 per common share (based on number of common shares currently outstanding) and $61.15 per common share on a fully diluted basis (assuming exercise of all the 1,488,478 outstanding warrants for cash). Additionally, the Company announced today that following...

Continue reading

Sigyn Therapeutics Announces Appointment of Jerry DeCiccio as Chief Financial Officer

SAN DIEGO, CA, Dec. 12, 2023 (GLOBE NEWSWIRE) — via NewMediaWire — Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB: SIGY), a development-stage medical technology company, today announced the appointment of Jerry DeCiccio, CPA, MBA, as Chief Financial Officer. Mr. DeCiccio brings more than 40 years of financial industry experience to the Company, which includes executive roles at publicly traded companies and Ernst & Young. Previously, he was CFO/COO at Intech Electromechanical (NASDAQ), CFO/COO at GTC Telecom (AMEX), CFO at Incomnet Communications (NASDAQ), and President at Cerebain Biotech Corp. (OTCBB). Mr. DeCiccio also served in senior financial roles at Parker Hannifin Corp. (NYSE), Waste Management Inc. (NYSE), and Newport Corp. (NASDAQ). In these roles, he managed finance, accounting, SEC reporting,...

Continue reading

Terravis Energy Begins Testing Prototype Residential Heat Pump at State-of-the-Art Testing Facility

West Seneca, New York, Dec. 12, 2023 (GLOBE NEWSWIRE) — Worksport Ltd. (Nasdaq: WKSP; WKSPW) (“Worksport” or the “Company”) is pleased to announce that its subsidiary, Terravis Energy, Inc. (“Terravis”), has refined and completed a working prototype of its Cold Climate, Air Source Residential Heat Pump intended for use in the residential home heating and cooling market, and has begun a testing program in a state-of-the-art climate chamber at Worksport’s Toronto facility. The company’s testing chamber conducts extensive cold weather trials during product development. For the Heat Pump, Terravis executes detailed tests that monitor performance across a range of 12 temperature points from 14ºF (-10ºC) to -31ºF (-35ºC). These tests include checking 4 refrigerant pressure zones, airflow, and the energy consumption of each component....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.